Orthopediatrics Corp (NASDAQ:KIDS) shares saw unusually-high trading volume on Friday . Approximately 965,661 shares traded hands during mid-day trading, an increase of 1,458% from the previous session’s volume of 61,989 shares.The stock last traded at $33.10 and had previously closed at $30.00.
KIDS has been the topic of several recent analyst reports. BidaskClub upgraded shares of Orthopediatrics from a “sell” rating to a “hold” rating in a research note on Wednesday, November 28th. Zacks Investment Research downgraded shares of Orthopediatrics from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 14th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $31.33.
The stock has a market capitalization of $383.70 million, a PE ratio of -5.81 and a beta of 0.74. The company has a debt-to-equity ratio of 0.62, a quick ratio of 3.23 and a current ratio of 5.67.
Orthopediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Wednesday, October 31st. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.03). The company had revenue of $15.82 million for the quarter, compared to analyst estimates of $15.19 million. Orthopediatrics had a negative return on equity of 65.26% and a negative net margin of 55.97%. The firm’s quarterly revenue was up 27.8% on a year-over-year basis. During the same quarter last year, the company earned ($1.70) EPS. Equities research analysts expect that Orthopediatrics Corp will post -0.95 earnings per share for the current year.
In related news, Director Kevin Unger sold 1,000 shares of the company’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $33.22, for a total transaction of $33,220.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 46.10% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. First Light Asset Management LLC lifted its position in Orthopediatrics by 6.8% during the 2nd quarter. First Light Asset Management LLC now owns 124,108 shares of the company’s stock worth $3,306,000 after buying an additional 7,923 shares in the last quarter. Indiana Trust & Investment Management CO acquired a new position in Orthopediatrics during the 3rd quarter worth about $248,000. DF Dent & Co. Inc. lifted its position in Orthopediatrics by 4.5% during the 2nd quarter. DF Dent & Co. Inc. now owns 104,074 shares of the company’s stock worth $2,773,000 after buying an additional 4,453 shares in the last quarter. Kornitzer Capital Management Inc. KS lifted its position in Orthopediatrics by 73.1% during the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 76,000 shares of the company’s stock worth $2,025,000 after buying an additional 32,100 shares in the last quarter. Finally, BlackRock Inc. lifted its position in Orthopediatrics by 74.9% during the 2nd quarter. BlackRock Inc. now owns 341,196 shares of the company’s stock worth $9,090,000 after buying an additional 146,115 shares in the last quarter. Institutional investors and hedge funds own 40.42% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2018/12/07/orthopediatrics-kids-sees-large-volume-increase.html.
About Orthopediatrics (NASDAQ:KIDS)
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Read More: Rule of 72
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.